Arya Sciences

Nautilus set to go public in reverse merger with Perceptive SPAC, aims to test proteomics platform with big-name backers
Endpoints
Tue, 02/9/21 - 11:21 am
Nautilus Biotechnology
NASDAQ
SPAC
IPOs
reverse merger
M&A
Arya Sciences
Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq
BioSpace
Wed, 10/28/20 - 11:09 pm
Pfizer
Cerevel Therapeutics
SPAC
Arya Sciences
NASDAQ
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
COVID-19
M&A
AbbVie
Allergan
Arya Sciences
Immatics
AcelRx
Tetraphase
Gilead Sciences
Forty Seven
Thermo Fisher
Stryker
Wright Medical